To include your compound in the COVID-19 Resource Center, submit it here.

University of Pennsylvania, Biogen deal

Biogen and the university partnered to develop gene therapies for eye, skeletal muscle and CNS conditions. The university will receive $20 million up

Read the full 232 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE